The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma. [electronic resource]
Producer: 20120815Description: 555-61 p. digitalISSN:- 1463-1318
- Adenocarcinoma -- metabolism
- Adult
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- therapeutic use
- Apoptotic Protease-Activating Factor 1 -- metabolism
- Biomarkers, Tumor -- metabolism
- Chemoradiotherapy
- Chi-Square Distribution
- Cyclin-Dependent Kinase Inhibitor p21 -- metabolism
- Cyclin-Dependent Kinase Inhibitor p27 -- metabolism
- Cyclooxygenase 2 -- metabolism
- Dose Fractionation, Radiation
- Female
- Fluorouracil -- therapeutic use
- Humans
- Male
- Middle Aged
- Multivariate Analysis
- Neoadjuvant Therapy
- Neoplasm Staging
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Rectal Neoplasms -- metabolism
- Statistics, Nonparametric
- Tumor Suppressor Protein p53 -- metabolism
- Vascular Endothelial Growth Factor A -- metabolism
- bcl-2-Associated X Protein -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.